Skip to main content

Roll Call Vote #103 · 119th Congress · Session 2 · Apr 23, 2026, 2:51 AM (ET)

On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)

Amendment S.Amdt. 5336 (To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.)

Amendment Rejected (48-50)
48 Yea
50 Nay
← Vote #102 Vote #104 →

How the Parties Voted

Republican 53 senators

2 Yea / 50 Nay

1 not voting or present

Majority position: Nay

Democrat 45 senators

44 Yea / 0 Nay

1 not voting or present

Majority position: Yea

Independent 2 senators

2 Yea / 0 Nay

Majority position: Yea

Crossed Party Lines

Full Roll Call: How Every Senator Voted

Yea 48

Nay 50

Not Voting 2

Source: Official U.S. Senate roll call vote data (senate.gov ↗).